Postoperative chylous fistula after neck dissection is an uncommon complication associated with significant patient morbidity. Octreotide acetate is a somatostatin analogue established in the treatment of chylothorax; however, its utility in the management of cervical chylous fistulae has not been fully evaluated. The investigators hypothesized that chylous fistula can be managed by a combination of octreotide and peripheral total parenteral nutrition (TPN). A retrospective review of cases compiled at our institution from 2009 to 2015 was conducted. Ten patients, all men, were identified as having a postoperative chylous fistula after a neck dissection. All patients were treated with peripheral TPN and intravenous octreotide. Mean age of the patients was 63.0 years (range 49 to 82). Five (50.0%) had a neck dissection for the management of metastatic nasopharyngeal carcinoma and had previous neck irradiation. In 8 (80%) patients, chylous fistula occurred in the left neck. Seven (70.0%) of the leaks occurred within the first 2 postoperative days. Eight (80%) leaks were controlled using TPN and octreotide, with 2 (20%) patients requiring surgical intervention. No factors were significant in the successful conservative management of chylous fistulae. One patient with a chylous fistula of 1,800 ml/day was managed successfully without surgical intervention. The results of this case series suggest that chylous fistulae may be managed conservatively with octreotide and TPN. However, long-term evaluation is needed to define if and when surgical intervention is required for control. Volume 96, Number 7 www.entjournal.com 265 CONSERvATIvE mANAGEmENT Of POSTOPERATIvE CHYLOUS fISTULA wITH OCTREOTIDE AND PERIPHERAL TOTAL PARENTERAL NUTRITION Figure. This algorithm depicts our current management of chylous fistulae after a neck dissection (TPN = total parenteral nutrition).
Introduction
Cervical chylous fistulae after neck dissections are a troublesome yet relatively uncommon complication, with incidence rates in the literature varying from 1 to 6%. 1, 2 They most commonly occur on the left side and are less likely on the right side, where the right lymphatic duct drainage occurs or rarely where the thoracic duct terminates into the right internal jugular vein.
The concern regarding chylous fistulae stems from the electrolyte imbalances and edema resulting in hypovolemia. There is also the potential for shock, nutritional deficiencies, loss of lymphocytes that results in decreased immune function, potentially leading to infection and sepsis, although these are less likely in cervical chylous fistulae as compared to chylothorax.
Recognizing and managing a chylous fistula intraoperatively is the most effective approach to management. If detected postoperatively, however, management of a low-output fistula through conservative measures including dietary changes, somatostatin analogues, pressure dressing, and negative-pressure wound management has been suggested, with surgical intervention reserved for a high-output fistula. [2] [3] [4] [5] [6] Opinions vary regarding the optimal management and timing of interventions of postoperative chylous Conservative management of postoperative chylous fistula with octreotide and peripheral total parenteral nutrition Jason Y.K. Chan, MBBS; Eddy W.Y. Wong, FRCSEd(ORL), FHKCORL; S.K. Ng, FRCSEd(ORL), FHKCORL; C. Andrew van Hasselt, FCS(SA)ORL; Alexander C. Vlantis, FCS(SA)ORL fistulae. Here we present our institution's experience and discuss our observations during management of this complication with the use of peripheral total parenteral nutrition (TPN) and octreotide acetate.
Patients and methods
The study was approved by the Institutional Review Board of the hospital authority CUHK/NTEC cluster, Hong Kong. The study was prepared in accordance with the Declaration of Helsinki.
A retrospective review of all patients diagnosed with a chylous fistula at our institution between July 1, 2009, and May 30, 2015, was performed from all patients that had undergone a neck dissection. In all patients, a chylous fistula was diagnosed on a clinical basis after observation of the classic milky output from drains.
All patients in this series were managed conservatively with peripheral TPN and the somatostatin analogue octreotide. Octreotide was initially started as an intravenous injection at 100 µg every 8 hours and stepped up to 200 µg every 8 hours if response in chylous fistula output was minimal. All surgical procedures were performed by staff at the Department of Otorhinolaryngology, Head and Neck Surgery, Prince of Wales Hospital, Hong Kong.
Statistical analysis of the data was performed using the Statistical Package for the Social Sciences software (v. 20.0). Categorical data were compared using the chi-square test or Fisher exact test; p < 0.05 was used as a significance level.
Results
A total of 10 patients, all men, had chylous fistulae after neck dissections over this period. Table 1 summarizes the patient data in our series. Over the study period, 438 neck dissections were performed, representing an incidence rate of 2.3% for chylous fistulae. Most chylous fistulae were in the left neck. Five were salvage neck dissections for patients with metastatic nasopharyngeal carcinoma. Only 1 patient had a peak chylous fistula output of >1,000 ml/24 hour.
Five (50%) of the chylous fistulae were identified intraoperatively. Three were repaired with sutures with or without fibrin sealant, 1 was repaired with a free strap muscle patch and fibrin sealant, and the final patient's fistula was repaired with a free sternocleidomastoid muscle patch and Surgicel.
All patients received conservative management consisting of peripheral TPN and octreotide. A trial with a medium-chain triglyceride (MCT) diet was initiated in 3 patients, all of whom were converted to TPN. One patient had a pressure dressing applied but did not tolerate the therapy. Eight patients were successfully treated with TPN and octreotide alone, with a mean drainage duration of 11.9 days (range: 3 to 24). One patient had an output of 1,800 ml/24 hour at the time of chylous fistula diagnosis on postoperative day 1; the output decreased to 27 ml by postoperative day 4 and was finally controlled on postoperative day 14. No factor was a significant predictor for success of conservative medical management of a chylous fistula (table 2) . Three patients developed peripheral phlebitis at the peripheral TPN site that resolved with repositioning of the peripheral intravenous cannula. Two patients developed gastrointestinal (GI) bleeding, 1 of whom had 3 GI bleeds resulting in death.
Conservative medical management of the chylous fistula with peripheral TPN and octreotide failed in both patients who developed GI bleeding. One of these patients had an initial fistula output of 276 ml on postoperative day 1 that increased to 735 ml on postoperative day 3 despite TPN and octreotide. He was subsequently taken to the operating room, the fistula was identified, and the area oversewn with the scalene medius muscle while protecting the phrenic nerve; however, a small leak was still observed. Then Surgicel and Floseal were placed but the leak still continued. Finally, a pectoralis major flap was placed to control the leak. The other patient had a negative-pressure dressing placed but during the course of treatment developed GI bleeding resulting in mortality.
Discussion
This is, to the best of our knowledge, the first case series documenting the use of peripheral TPN and octreotide in all patients with a chylous fistula, 80% of which were controlled successfully. The incidence rate of 2.3% for chylous fistula from a cohort of 438 neck dissections corresponds with reports in the literature of rates from 1 to 6%. 1,2 Unique to our cohort, 5 patients (50.0%) had neck dissections for Epstein-Barr virus related to metastatic nasopharyngeal carcinoma. Furthermore, most (80%) of the chylous fistulae were found on the left side, reflecting that chylous fistulae occur more commonly on the left than on the right side. 1, 7, 8 Identification of a chylous fistula may occur both intraoperatively or postoperatively. If discovered intraoperatively, all efforts should be made to stop the chylous fistula. Manipulation of the leaking sites should be minimal because of the fragility of the duct. 8 In addition, suture needles should not be passed directly through the duct. 3 Adjunctive measures have been described to supplement suturing if this technique fails, including the use of local muscle flaps and the regional pedicle pectoralis major flap. 9 Alternatively, use of fibrin glue and cyanoacrylate glue has also been reported.
Five of our patients (50%) who had chylous fistula detected intraoperatively developed postoperative chylous fistulae, a rate that is within the range of other studies. 8 Without information on the incidence of intraoperative chylous fistulae, however, we are unable to comment on the success of our management protocol for intraoperative chylous fistulae. Postoperatively, once a chylous fistula is identified, we now proceed to peripheral TPN and octreotide as first-line conservative treatment, using a treatment algorithm as outlined in the figure, with the benefit of allowing adequate time for conservative measures to have an effect at a risk of a prolonged hospital stay and prolonged chylous fistula. The choice of this regimen was based on previous undesirable experiences with alternate conservative measures including pressure dressings, MCTs, and negative-pressure wound therapy.
Pressure dressings are intended to compress the leaking chyle vessel and allow time for closure. However, we have found that this practice causes significant patient discomfort, which has also been described in other studies, with the added difficulty of placing adequate pressure in the supraclavicular fossa while ensuring skin flap viability. 1, 3 MCTs are directly absorbed into the portal blood and bypass the lymphatic system; they have been reported to be useful in the management of chylous fistulae. 3 However, in 1 report, an MCT and water-only diet increased drainage output from a chylothorax in 20% of patients. 10 These conflicting viewpoints reflect the small number of cases and a lack of a clear role for MCT in the management of chylous fistulae.
Negative-pressure wound therapy has been described by Kadota et al in the management of an intractable chylous fistula. 4 We attempted negative wound pressure without effect in 1 patient in whom conservative management had failed. TPN has been shown to be effective in managing chylous fistula, and octreotide has demonstrated effectiveness in the management of chylothorax. The combination of the two therapies targets absorption and production of chyle, and has proven to be effective at our center, as we describe, with the management of one particularly high-output chylous fistula. The minor complication of phlebitis was managed with simple repositioning of peripheral intravenous cannulas.
The 2 cases of GI bleeding are unlikely related to therapy, as TPN has not been shown to cause GI bleeding and octreotide is used in the treatment of GI bleeding. Thus, this complication is most likely related to other patient factors.
Our study is limited by its small size and observational nature. Also, given the diverse range of treatment regimens reported in the literature, albeit in predominantly case studies, consensus on the conservative management of chylous fistulas is lacking. In the future, controlled studies likely involving multiple centers will be useful to define a treatment regimen for chylous fistulae.
In summary, initial conservative management of chylous fistulae is recommended regardless of initial output. TPN and octreotide were effective in our series with minimal associated morbidity. No factors were found to be significantly associated with the resolution of chylous fistulae using conservative management.
